通过中断蛋白激酶C信号转导途径调节药物诱导的细胞凋亡：一种新的治疗策略。 - Suppr

Suppr

超能文献

Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.

作者信息

Grant S, Jarvis W D

机构信息

Departments of Medicine and Pharmacology and Toxicology, Medical College of Virginia, Richmond, Virginia 23298, USA.

出版信息

Clin Cancer Res. 1996 Dec;2(12):1915-20.

PMID:9816149

Abstract

摘要

相似文献

Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.通过中断蛋白激酶C信号转导途径调节药物诱导的细胞凋亡：一种新的治疗策略。

Clin Cancer Res. 1996 Dec;2(12):1915-20.

Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.RAF/丝裂原活化蛋白/细胞外信号调节激酶激酶/细胞外信号调节激酶信号通路的激活介导了白屈菜红碱诱导骨肉瘤细胞凋亡的过程。

Clin Cancer Res. 2008 Oct 15;14(20):6396-404. doi: 10.1158/1078-0432.CCR-07-5113.

Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.雷帕霉素、环孢素A以及磷脂酰肌醇3激酶、蛋白激酶C和蛋白酪氨酸激酶的抑制剂可阻断T细胞活化诱导的小鼠TRAIL（肿瘤坏死因子相关凋亡诱导配体）表达：通过T细胞受体信号通路诱导TRAIL的证据。

Exp Cell Res. 1999 Oct 10;252(1):96-103. doi: 10.1006/excr.1999.4631.

Potential for protein kinase C inhibitors in cancer therapy.蛋白激酶C抑制剂在癌症治疗中的潜力。

Cancer Treat Res. 1995;78:3-27. doi: 10.1007/978-1-4615-2007-8_1.

c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.c-Myc通过在p38信号级联反应中作用于凋亡信号调节激酶1（Ask1）的上游，增强凋亡的线粒体途径。

Biochem J. 2003 Jun 1;372(Pt 2):631-41. doi: 10.1042/BJ20021565.

Protein kinase C-alpha in prostate cancer.蛋白激酶C-α与前列腺癌

BJU Int. 2004 May;93(7):1076-81. doi: 10.1111/j.1464-410X.2003.04784.x.

Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.水飞蓟宾保护的异丙肾上腺素诱导的大鼠心肌细胞凋亡过程中，细胞外信号调节激酶的激活是由酪氨酸激酶途径介导且依赖蛋白激酶C的。

Acta Pharmacol Sin. 2007 Jun;28(6):803-10. doi: 10.1111/j.1745-7254.2007.00472.x.

Signal transduction inhibitors as novel anticancer drugs: where are we?作为新型抗癌药物的信号转导抑制剂：我们目前处于什么阶段？

Ann Oncol. 1992 Jul;3(7):527-31. doi: 10.1093/oxfordjournals.annonc.a058253.

Protein kinase inhibitors as a therapeutic modality.蛋白激酶抑制剂作为一种治疗方式。

Acc Chem Res. 2003 Jun;36(6):462-9. doi: 10.1021/ar0201207.

Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).PP1和GL-2003（抗PAK1药物，酪氨酸激酶抑制剂）联合对人胰腺癌及NF1缺陷型乳腺癌小鼠异种移植瘤的信号治疗

Cancer Lett. 2007 Jan 8;245(1-2):242-51. doi: 10.1016/j.canlet.2006.01.018. Epub 2006 Mar 15.

引用本文的文献

Protein kinases and multidrug resistance.蛋白激酶与多药耐药性。

Cytotechnology. 1998 Sep;27(1-3):203-24. doi: 10.1023/A:1008073006495.

Signaling inhibitors in the treatment of prostate cancer.信号传导抑制剂在前列腺癌治疗中的应用

Invest New Drugs. 2002 May;20(2):159-72. doi: 10.1023/a:1015678427111.

Protein kinase C targeting in antineoplastic treatment strategies.抗肿瘤治疗策略中的蛋白激酶C靶向作用

Invest New Drugs. 1999;17(3):227-40. doi: 10.1023/a:1006328303451.

Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.

Med Oncol. 1999 Apr;16(1):58-64. doi: 10.1007/BF02787360.

Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes.肾上腺素能激动剂对成年大鼠静止期和再生期肝细胞有丝分裂原激活蛋白激酶及应激激活蛋白激酶级联反应的差异调节

Mol Cell Biol. 1997 Jul;17(7):3556-65. doi: 10.1128/MCB.17.7.3556.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验